TOTAL SYNTHESIS OF 2'-DEOXY-2'-ARAFLUORO-TUBERCIDIN, 2'-DEOXY-2'-ARAFLUORO-TOYOCAMYCIN, 2'-DEOXY-2'-ARAFLUORO-SANGIVAMYCIN AND CERTAIN RELATED NUCLEOSIDES
Bk. Bhattacharya et al., TOTAL SYNTHESIS OF 2'-DEOXY-2'-ARAFLUORO-TUBERCIDIN, 2'-DEOXY-2'-ARAFLUORO-TOYOCAMYCIN, 2'-DEOXY-2'-ARAFLUORO-SANGIVAMYCIN AND CERTAIN RELATED NUCLEOSIDES, Journal of the Chemical Society. Perkin transactions. I, (12), 1995, pp. 1543-1550
A total synthesis of novel nucleosides 2'-deoxy-2'-arafluoro-tubercidi
n 12, -toyocamycin 23, -sangivamycin 24 and -thiosangivamycin 25 has b
een accomplished for the first time starting from 4-chloropyrrolo[2,3-
d]pyrimidine 4, and 5-(ethoxymethyleneamino)pyrrole-3,4-dicarbonitrile
16. The sodium-salt glycosylation of secondary amines 4 and 16 with -
benzoyl-2-deoxy-2-fluoro-alpha-D-arabinofuranosyl bromide 5 gave the m
ajor beta-nucleosides 6 and 17 along with minor. amounts of alpha-anom
ers 7 and 18. Ammonolysis of compound 6 gave the tubercidin analogue 1
2. The annulation of epimers 17 and 18 furnished the bromotoyocamycin
21 and its alpha-anomer 22, respectively. Compound 21 was converted in
to analogues of toyocamycin 23, sangivamycin 24 and thiosangivamycin 2
5. Similar functional-group manipulation of substrates 7 and 22 provid
ed the alpha-anomers of compounds 12, 23, 24 and 25. Among the nucleos
ides tested, the sangivamycin 24 and thiosangivamycin 25 analogues hav
e shown some interesting anti-(human cytomegalovirus) activity and it
was observed that compound 25 is more active than compound 24, but les
s potent than 9-(1,3-dihydroxypropan-2-yloxymethyl)guanine in vitro.